Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
HER2-low and HER2-zero TNBC patients show significant clinicopathological differences. Compared to HER2-zero, HER2-low status is linked to better long-term prognosis and serves as an independent low-risk factor for RFS in TNBC patients.
Authors
- Hongwu Chu
- Ziyan Zhang (ORCID: https://orcid.org/0009-0006-1050-8045)
- Xin Liu (ORCID: https://orcid.org/0000-0001-8228-3689)
- Xiao Zou (ORCID: https://orcid.org/0000-0002-3666-5536)
- Meiyan Liu (ORCID: https://orcid.org/0000-0001-9114-9633)
- Kaihua Zhao
Institutions
- Qingdao University (CN)
- Sun Yat-sen University (CN)
- Hunan Normal University (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Qingdao Municipal Hospital (CN)
- Qingdao Women and Children's Hospital (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1007/s00432-024-06069-7
- Citations
- 2
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.57